Streetwise Reports' Article Archives — July 2020 back to current month (30)
Coverage Initiated on 'Emerging Colossus in Diagnostics and Life Science' (07/29/2020)
Meridian Bioscience's business segments, revenue and growth as well as COVID-19's positive impact on them are reviewed in an H.C. Wainwright & Co. report.
Digital Health Firm Signs Deal to Acquire Vancouver Medical Clinic Serving 60,000 Patients (07/29/2020)
CloudMD reported it entered into a definitive agreement to acquire South Surrey Medical Clinic in Metro Vancouver in a combination stock and cash deal valued at CA$700,000.
Kodak Shares Triple in a Flash on $765 Million Loan from DFC for New Pharmaceutical Unit (07/28/2020)
Eastman Kodak shares traded more than 200% higher after the company reported it is forming a new business unit to produce essential pharmaceutical components funded by the U.S. International Development Finance Corporation.
TCR2 Therapeutics Reports Positive Results in Mesothelin-Expressing Solid Tumor Study (07/27/2020)
Shares of TCR2 Therapeutics traded 30% higher after the firm released encouraging results from the Phase 1 portion of its clinical study of TC-210 in treating advanced mesothelin-expressing solid tumors.
Milestone Shares More than Double After Presenting Updated Clinical Plan for Heart Condition (07/23/2020)
Shares of Milestone Pharmaceuticals traded 150% higher after the company reported regulatory guidance and updated its clinical development plan for etripamil nasal spray designed for self-administered use in PSVT treatment.
Biopharma's Therapeutic Jumps to Phase 2 Testing for COVID-19 'to Shut Down the Cytokine Storm' (07/22/2020)
A development update on Sorrento Therapeutics' three coronavirus-related products is provided in a Dawson James report.
HCA Healthcare Shares Move Up on Q2 Earnings and Resumption of Non-Emergency Procedures (07/22/2020)
Shares of HCA Healthcare traded more than 10% higher after the company reported Q2/20 financial results and advised it has seen a gradual rise in patient volumes in May and June for elective and non-emergency procedures.
Owens & Minor Shares Trade 75% Higher on Preliminary Q2 Earnings and Raised FY Guidance (07/21/2020)
Shares of Owens & Minor reached a new 52-week high after the company reported preliminary Q2/20 results and raised FY/20 earnings guidance.
AI Tech Firm Provides COVID-19 Contact Tracing Solution Update (07/20/2020)
Loop Insights continues to educate governments and venue operators around the world about its easily implemented platform.
Innovative Telehealth Company to Acquire Firm with Mental Health Platform (07/18/2020)
With this transaction, CloudMD Software & Services will become Canada's first telemedicine company with both primary care and mental health care components.
Dynavax Shares Rise 20% on Partnership with Mount Sinai to Develop Universal Flu Vaccine (07/17/2020)
Shares of Dynavax Technologies reached a new 52-week high after the company reported that it is collaborating with Mount Sinai to develop a universal influenza vaccine candidate with CpG 1018 adjuvant.
Cheap Valuation and Fastest Revenue Growth in Telemedicine? Analyst Says Yes. (07/17/2020)
In the time of Covid-19, Peter Epstein of Epstein Research breaks down the investment opportunity offered by CloudMD.
Threat Detection Company's AI Division Partners with Healthcare Firm to Increase Cancer Testing Access (07/16/2020)
Patriot One Technologies reported its Xtract AI division is working with Canexia Health to increase access to cancer testing as part of the Digital Technology Supercluster COVID-19 Program project.
AC Immune Shares Rise 19% as Firm Advances Alzheimer's Vaccine in Phase 1b/2a Trial (07/16/2020)
AC Immune SA shares set a new 52-week high after the Swiss biotech firm reported that interim data from its Phase 1b/2a phospho-Tau Alzheimer's Vaccine study reconfirms promising safety and Tau-specific immunogenicity observed in the prior clinical trial.
Taiwan Liposome Shares Rise 60% on Inhalable Liposomal HCQ Potential Covid-19 Treatment Claims (07/15/2020)
Shares of Taiwan Liposome Co. reached a new 52-week high after the company released a manuscript describing how its inhalable liposomal hydroxychloroquine may provide clinical benefit and offer a potential treatment for Covid-19.
Virtual Healthcare Tech Firm's Contract in Puerto Rico Is Its Largest by 400% (07/15/2020)
Reliq Health Technologies' agreement with digiiMED makes its platform available to more than 200,000 patients.
Potential Covid-19 Treatment Is Ready for Prime Time (07/14/2020)
Small-cap Algernon Pharmaceuticals is about to begin a multinational Phase 2b/3 trial for Ifenprodil, a repurposed drug with a known safety record.
INmune Bio Shares Double after Reporting Positive Phase 1b Alzheimer's Trial Data (07/14/2020)
Shares of INmune Bio reached a new 52-week high after the company reported interim data from its Phase 1b study of XPro1595 that demonstrated decreased neuroinflammation in Alzheimer's patients.
Analyst: Integrated Model Positioned to Monetize on Telehealth Emergence (07/13/2020)
Echelon Capital Markets initiates coverage and explains why it is bullish on CloudMD Software & Services.
Biotech Partners to Develop, Offer Alzheimer's Disease Tests (07/13/2020)
ProMIS Neurosciences and its collaborator make their relationship official with a joint venture agreement.
BioNTech Shares Rise as FDA Grants It and Partner Pfizer Fast Track Status for Two Covid-19 Vaccine Candidates (07/13/2020)
Shares of BioNTech SE traded 15% higher after the company reported that, together with its partner Pfizer, it has received FDA Fast Track designation for two separate mRNA-based vaccine candidates against SARS-CoV-2.
Threat Detection Company Forms Partnership to Advance Covid-19 Pathogen Screening (07/12/2020)
Patriot One Technologies reported it is collaborating with ecoMine Technologies to advance pathogen screening applications as part of Canada's Digital Technology Supercluster's Covid-19 program.
Altimmune Shares Up 20% Upon Forming Partnership for Intranasal COVID-19 Vaccine (07/09/2020)
Altimmune shares reached a new 52-week high after the company reported it is collaborating with DynPort Vaccine on U.S. government funding efforts for AdCOVID™, its COVID-19 vaccine candidate.
Biotech with Phase 3 Rheumatoid Arthritis and Psoriasis Trials Raises Capital, Now 'Funded Through Catalysts' (07/08/2020)
An update on Can-Fite BioPharma's multiple drug treatment trials is provided in a Dawson James report.
Preclinical COVID-19 Vaccine Data 'Encouraging' (07/08/2020)
Updates on Sorrento Therapeutics' two coronavirus-related products are provided in an H.C. Wainwright & Co. report.
Biopharma Starts Enrollment Screening for Phase 2 Pulmonary Fibrosis, Cough Trial (07/08/2020)
In the study, Algernon Pharmaceuticals will test an existing drug that is being repurposed for these indications.
Analyst: G1 Minimizes the Carnage of Chemotherapy (07/01/2020)
ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA.
'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug (07/01/2020)
Axsome Therapeutics' latest news and clinical outlook are discussed in an H.C. Wainwright & Co. report.
Life Sciences Firm Submits IND Application to FDA for Phase 3 COVID-19 Study (07/01/2020)
Revive Therapeutics submitted an Investigational New Drug Application to the FDA for a Phase 3 confirmatory study of Bucillamine for treatment in SARS-CoV-2.
Akero Therapeutics Shares Rise on Positive Data from Phase 2a NASH Study (07/01/2020)
Akero Therapeutics shares traded 28% higher and established a new 52-week high after the company reported that it recorded positive histological data across all Efruxifermin dosage groups in its Phase 2a BALANCED Study in NASH patients.
More Archives
2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
